Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001
about
A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigmOutcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trialSurvival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis.Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation.Improved prognosis for older adolescents with acute lymphoblastic leukemia.Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.Survival from childhood cancer in northern England, 1968-2005.Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remissionOutcomes after induction failure in childhood acute lymphoblastic leukemia.Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Natural killer cell therapy in children with relapsed leukemia.The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialSecond malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.The evolution of clinical trials for infant acute lymphoblastic leukemia.Treatment of acute lymphoblastic leukemia in adolescents and young adults.Predicting relapse risk in childhood acute lymphoblastic leukaemia.Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia.Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-FrankSurvival From Childhood Hematological Malignancies in Denmark: Is Survival Related to Family Characteristics?Non-irradiated female survivors of childhood acute lymphoblastic leukaemia are at risk of long-term increases in weight and body mass index.The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia.Survival from tumours of the central nervous system in Danish children: Is survival related to family circumstances?Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL).A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center.Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
P2860
Q26866379-B4E30AB4-FEDD-4756-91CF-9E43267CF0B3Q28543517-3C6E3A9F-FAD2-42A4-92F3-F244B32A1D64Q30572783-10C832FC-09AA-4C12-AB01-B4A57CF0185EQ30631947-C25A8216-ACEE-47BD-9146-89B271EF2294Q33711119-8D04759A-64D8-4A39-AF59-C3341DC85F8BQ34488796-1AA676A0-5327-4B32-BE3E-C7A6D4D717DBQ34621846-748326FF-C165-405C-B7E2-6679F3E6CDF3Q34679298-A1ACE478-3535-4F48-8B30-6CC9DEBAB966Q34707213-CE408350-7435-4FAB-AAF5-384E26903086Q34764504-23220202-0D0A-4C43-8DC8-01CBC7C29344Q35112206-20DC0716-5918-4D86-8E73-8F252E7F16ADQ35620600-A5A50D3D-B9F3-4C2C-9C45-D28C2AFCBB52Q35738417-F503E267-9D0C-496D-B8E5-A4E50736287FQ36023505-F020A1EB-75EA-4D97-A142-7282F672DFAAQ36029619-324DDB44-6749-4D02-A279-A2A1B330C01DQ36058255-348F9463-79A8-43F5-AF8A-50F40FBF3D52Q36163029-E7CF25AE-5BC2-440A-B6CE-5DDDB4AF448BQ36251948-E4A22FBF-662F-49C9-B369-A226C0F4B0CBQ37078647-AD164CAC-4F91-431F-9A6C-9958ABF9D602Q37129069-C1F83DEA-3402-440B-A145-88398E9F781FQ37252283-0DBF9023-FE98-4AE9-8A29-931AED4D09C1Q37322911-4DA0BF16-0BB6-4FFF-811C-7A1DACEFEBF7Q37429718-51D27E4E-6FDE-4FAB-A8E9-8653B28D2DB9Q37730023-3FEB7527-D070-4731-BB40-2253BB3599FFQ37899785-24D653A4-A72B-4B78-B566-E0736CEC4A40Q38117685-5756F22A-0FA0-4F5A-976E-D4F745DC9559Q38909642-ED6EF8D3-8C4A-4D9F-9DAE-17E52205C624Q38984055-142243C3-2636-4FC2-A856-E4EFBBD41CFCQ39674477-FE5F8666-6919-433B-8039-BD3E6C4E6CC0Q40097280-14CA782D-55A3-4275-9FE5-4E3FBB35B9E6Q40874665-BDFDA865-B158-487B-9C0B-C3C14316EF99Q43545367-8C40E475-8F2C-44C1-9B90-9B089DEBADA6Q47094715-CFF9D3D5-8DEC-4AB0-969B-0C0A5CFA6385Q47669044-732B2E8F-09F6-4521-A4AA-5366B3256CE7Q47884623-E0C498B6-0210-46DF-9873-1A901F5624E5Q49843440-7D5994B6-018B-45DE-AF04-E7F6B0CE1A36Q51416496-E5B0F167-CBD2-43B8-8CF4-31B52967A009Q52889397-3C885C3A-DAE7-4D2E-949D-406FFECD9997Q54295812-3CAAAE79-0915-48E3-A506-FBADA5779984Q58481795-B56FB151-0B37-4A45-BCEC-53EAA32561FF
P2860
Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@ast
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@en
type
label
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@ast
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@en
prefLabel
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@ast
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@en
P2093
P2860
P356
P1433
P1476
Long-term follow-up of the Uni ...... hoblastic leukaemia, 1980-2001
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2009.256
P577
2009-12-10T00:00:00Z
P5875
P6179
1028995056